推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Cell International 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
Springer Nature特刊征稿
已发表SCI?是时候来Springer出书了!

按研究方向查看:


Cancer Cell International期刊基本信息Hello,您是该期刊的第203775位访客

基本信息 登录收藏
期刊名字Cancer Cell InternationalCancer Cell International

CANCER CELL INT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.7
88人评分
我要评分

声誉
7.2

影响力
6.0

速度
7.4

期刊ISSN1475-2867
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:6.99
2025-2026自引率1.4%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
6.097数据由网友[海旭]收集提供
h-index 47
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
10.501.7501.308
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Genetics
Q129 / 357
大类:Biochemistry, Genetics and Molecular Biology
小类:Oncology
Q150 / 428
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q144 / 233

期刊简介
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.

Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
期刊官方网站http://cancerci.biomedcentral.com
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://submission.nature.com/new-submission/12935/3
作者指南网址http://cancerci.biomedcentral.com/submission-guidelines
该期刊中国学者近期发文 - NewRETRACTION: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
Author: Li, Yue; Li, You; Chen, Yao; Xie, Qian; Dong, Ningning; Gao, Yanjun; Deng, Huan; Lu, Chunhua; Wang, Suihai
Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04327-x


Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma (vol 26, 68, 2026)
Author: Zhang, Wei; Xia, Shunjin; Xiao, Yanming; Liu, Hongwei; Wang, Chaoqian; Dai, Luohuan; Chen, Yinhua; Lin, Xuelei; Liu, Hongyi; Jiang, Nian
Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04294-3


TRPM2: a pivotal player in tumor progression and a promising therapeutic target (vol 25, 356, 2025)
Author: Chen, Zhigang; Wu, Zhenheng; Xu, Tianhan; Yu, Fuqian; Wang, Dongmei
Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04255-w


RETRACTION: M3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway
Author: Feng, Yujie; Hu, Xiao; Liu, Guangwei; Lu, Lianfang; Zhao, Wei; Shen, Fangzhen; Ma, Kai; Sun, Chuandong; Zhu, Chengzhan; Zhang, Bingyuan
Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04301-7


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Cell International的语言要求,还能让Cancer Cell International编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Cell International编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(6篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2190; USD2990; EUR2490; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:cancer cell biology、cell culture
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向ONCOLOGY-
出版国家或地区ENGLAND
出版语言English
出版周期Irregular
出版年份2001
年文章数 479点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比:
文章 ÷(文章 + 综述)
71.19%
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:预警等级:中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
ONCOLOGY
肿瘤学
4区3区2区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 4区3区4区
ONCOLOGY
肿瘤学
1区4区3区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
ONCOLOGY
肿瘤学
2区1区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-2867%5BISSN%5D
平均审稿速度网友分享经验:
平均1月
平均录用比例网友分享经验:
约50%
版面费/APC文章处理费信息
文章处理费:需要( GBP2190; USD2990; EUR2490; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Cell International顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(6篇)
提交文稿
期刊常用信息链接
同领域相关期刊 Cancer Cell International期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Cell International期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Cell International上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE898128
    JOURNAL OF ETHNOPHARMACOLOGY802802
    Frontiers in Immunology745997
    BIOMEDICINE & PHARMACOTHERAPY725651
    BIOMATERIALS715354
    Frontiers in Pharmacology714679
    PHYTOMEDICINE643360
    Frontiers in Oncology619142
    Biomedical Signal Processing and Control599905
    IEEE Journal of Biomedical and Health Informatics596850
  •  

    Cancer Cell International Cancer Cell International
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.RETRACTION: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis

    Author: Li, Yue; Li, You; Chen, Yao; Xie, Qian; Dong, Ningning; Gao, Yanjun; Deng, Huan; Lu, Chunhua; Wang, Suihai
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04327-x
        PubMed      DOI
    2.Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma (vol 26, 68, 2026)

    Author: Zhang, Wei; Xia, Shunjin; Xiao, Yanming; Liu, Hongwei; Wang, Chaoqian; Dai, Luohuan; Chen, Yinhua; Lin, Xuelei; Liu, Hongyi; Jiang, Nian
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04294-3
        PubMed      DOI
    3.TRPM2: a pivotal player in tumor progression and a promising therapeutic target (vol 25, 356, 2025)

    Author: Chen, Zhigang; Wu, Zhenheng; Xu, Tianhan; Yu, Fuqian; Wang, Dongmei
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04255-w
        PubMed      DOI
    4.RETRACTION: M3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway

    Author: Feng, Yujie; Hu, Xiao; Liu, Guangwei; Lu, Lianfang; Zhao, Wei; Shen, Fangzhen; Ma, Kai; Sun, Chuandong; Zhu, Chengzhan; Zhang, Bingyuan
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04301-7
        PubMed      DOI
    5.CD8+ T cell exhaustion driven by metabolic reprogramming

    Author: Deng, Wenzhi; Li, Chunhong; Wang, Qiang; Jiang, Xiulin; Xie, Yongzhi
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04287-2
        PubMed      DOI
    6.Clonal hematopoiesis in the pathogenesis of non-hematologic diseases with therapeutic potential

    Author: Lei, Lu; Xiong, Jie
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04285-4
        PubMed      DOI
    7.Targeting cell death: a promising approach for colorectal cancer therapy

    Author: Xiao, Chengfeng; Oyang, Linda; Jiang, Xianjie; Li, Shizhen; Peng, Qiu
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04261-y
        PubMed      DOI
    8.RNA modifications and cancer ferroptosis

    Author: Xie, Yingda; Sun, Bo; Chen, Wenjuan; Jia, Xueying; Fan, Yitao; Xu, Ziyi; Liu, Hongyan; Gu, Xinyu; Ma, Fuqiang
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04279-2
        PubMed      DOI
    9.RETRACTION: TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway

    Author: Ji, Kaihua; Lin, Kaili; Wang, Yan; Du, Liqing; Xu, Chang; He, Ningning; Wang, Jinhan; Liu, Yang; Liu, Qiang
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04286-3
        PubMed      DOI
    10.The cancer-testis lncRNA AC007271.3 acts as a decoy of MBP-1 and promotes chemotherapy resistance by inhibiting ferroptosis via c-Myc/GPX4 pathway in oral squamous cell carcinoma

    Author: Qiao, Zihe; Wu, Qingqing; Zhang, Xueni; Wang, Mohan; Zheng, Zenan; Fonseca, Shanoi T.; Lv, Xiaozhi
    Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04281-8
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    MMWR Surveillance Summaries093.20
    Journal of the National Cancer Center031.20
    Carbon Neutralization018.20
    Journal of Nanostructure in Chemistry027.90
    Journal of the National Comprehensive Cancer Network8819.40
    Journal of Advanced Research3621.70
    Soft Science014.30
    NEW ASTRONOMY REVIEWS5236.80
    Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery3126.60
    ACS Measurement Science Au014.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共790


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室